Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Spruce Biosciences, Inc. (SPRB) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Spruce Biosciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1683553.
Total stock buying since 2020: $38,247,728.
Total stock sales since 2020: $3,639,600.
Total stock option exercises since 2020: $12,221.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 4,172,336 | $3,407,836 | 954,000 | $0 |
| 2023 | 2,838,400 | $8,997,728 | 0 | $0 | 442,500 | $0 |
| 2022 | 0 | $0 | 0 | $0 | 37,500 | $0 |
| 2021 | 0 | $0 | 14,379 | $231,764 | 14,379 | $12,221 |
| 2020 | 1,950,000 | $29,250,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-12 | 0 | $0 | 0 | $0 | 954,000 | $0 |
| 2024-03 | 0 | $0 | 4,172,336 | $3,407,836 | 0 | $0 |
| 2023-12 | 0 | $0 | 0 | $0 | 255,000 | $0 |
| 2023-06 | 0 | $0 | 0 | $0 | 75,000 | $0 |
| 2023-02 | 2,838,400 | $8,997,728 | 0 | $0 | 0 | $0 |
| 2023-01 | 0 | $0 | 0 | $0 | 112,500 | $0 |
| 2022-06 | 0 | $0 | 0 | $0 | 37,500 | $0 |
| 2021-05 | 0 | $0 | 334 | $5,106 | 334 | $283 |
| 2021-04 | 0 | $0 | 14,045 | $226,658 | 14,045 | $11,938 |
| 2020-10 | 1,950,000 | $29,250,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-16 | Charlton Ralph William Iii (CHIEF MEDICAL OFFICER) | Option Ex | 58,350 | .00 | 0 |
| 2024-12-16 | Szwarcberg Javier B. (CHIEF EXECUTIVE OFFICER) | Option Ex | 200,700 | .00 | 0 |
| 2024-12-16 | Gharib Samir M. (PRESIDENT AND CFO) | Option Ex | 75,750 | .00 | 0 |
| 2024-12-10 | Charlton Ralph William Iii (CHIEF MEDICAL OFFICER) | Option Ex | 106,400 | .00 | 0 |
| 2024-12-10 | Szwarcberg Javier B. (CHIEF EXECUTIVE OFFICER) | Option Ex | 358,800 | .00 | 0 |
| 2024-12-10 | Gharib Samir M. (PRESIDENT AND CFO) | Option Ex | 154,000 | .00 | 0 |
| 2024-03-21 | Novo Holdings A/s (10% Owner) | Sale | 465,021 | .76 | 351,090 |
| 2024-03-20 | Novo Holdings A/s (10% Owner) | Sale | 359,979 | .73 | 264,224 |
| 2024-03-19 | Novo Holdings A/s (10% Owner) | Sale | 593,000 | .76 | 447,715 |
| 2024-03-18 | Novo Holdings A/s (10% Owner) | Sale | 842,020 | .77 | 646,671 |
| 2024-03-14 | Novo Holdings A/s (10% Owner) | Sale | 1,912,316 | .89 | 1,698,136 |
| 2023-12-15 | Charlton Ralph William Iii (Chief Medical Officer) | Option Ex | 31,750 | .00 | 0 |
| 2023-12-15 | Szwarcberg Javier B. (Chief Executive Officer) | Option Ex | 111,000 | .00 | 0 |
| 2023-12-15 | Gharib Samir M. (President & CFO) | Option Ex | 112,250 | .00 | 0 |
| 2023-06-30 | Gharib Samir M. (President & CFO) | Option Ex | 75,000 | .00 | 0 |
| 2023-02-16 | O'donnell Niall (Director) | Buy | 630,400 | 3.17 | 1,998,368 |
| 2023-02-16 | Novo Holdings A/s (10% Owner) | Buy | 2,208,000 | 3.17 | 6,999,360 |
| 2023-01-03 | Gharib Samir M. (President & CFO) | Option Ex | 75,000 | .00 | 0 |
| 2022-06-30 | Gharib Samir M. (President & CFO) | Option Ex | 37,500 | .00 | 0 |
| 2021-05-20 | Simpson Camilla V (Director) | Sale | 334 | 15.29 | 5,106 |
| 2021-05-20 | Simpson Camilla V (Director) | Option Ex | 334 | .85 | 283 |
| 2021-04-30 | Simpson Camilla V (Director) | Sale | 14,045 | 16.14 | 226,658 |
| 2021-04-30 | Simpson Camilla V (Director) | Option Ex | 14,045 | .85 | 11,938 |
| 2020-10-14 | Omega Fund Vi Gp, L.p. (10% Owner) | Buy | 250,000 | 15.00 | 3,750,000 |
| 2020-10-14 | Hansson Jonas (Director) | Buy | 250,000 | 15.00 | 3,750,000 |
| 2020-10-14 | Chaya Moghrabi Dina (Director) | Buy | 250,000 | 15.00 | 3,750,000 |
| 2020-10-14 | Muralidhar Bali (Director) | Buy | 200,000 | 15.00 | 3,000,000 |
| 2020-10-14 | Healthcap Viii, L.p. (Other) | Buy | 250,000 | 15.00 | 3,750,000 |
| 2020-10-14 | O'donnell Niall (Director) | Buy | 250,000 | 15.00 | 3,750,000 |
| 2020-10-14 | Rivervest Venture Fund Iv, L.p. (10% Owner) | Buy | 250,000 | 15.00 | 3,750,000 |
| 2020-10-14 | Novo Holdings A/s (10% Owner) | Buy | 250,000 | 15.00 | 3,750,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of SPRB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Spruce Biosciences, Inc. (symbol SPRB, CIK number 1683553) see the Securities and Exchange Commission (SEC) website.